John DaSilva

Scientist at Regeneron Pharmaceuticals

Speaker

John DaSilva, Ph.D., is Associate Director of Oncology & Immune-Oncology at Regeneron Pharmaceuticals. Experienced researcher in the fields of cancer cell signaling, biologics, biparatopic antibodies, and antibody drug conjugate (ADC) development. Demonstrated success producing preclinical data supporting INDs and guiding several development programs. Leading discovery and development team from initial ADC design and screening to delivery of clinical development candidates for the treatment of cancer.